L. Gou

发表

GBP 1 promotes erlotinib resistance via PGK 1 ‐ activated EMT signaling in non ‐ small cell lung cancer

Jian Zhang, Ting Wei, Lifang Cheng, 2020 .

UBE3A deletion enhances the efficiency of immunotherapy in non-small-cell lung cancer

Jian Zhang, Jie Shen, P. Luo, 2022, Bioengineered.

The Unique Characteristics of MET Exon 14 Mutation in Chinese Patients with NSCLC

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Acquired MET Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non–Small Cell Lung Cancer

Yi-long Wu, Jin-Ji Yang, S. Chuai, 2017, Clinical Cancer Research.

Differences in driver genes between smoking‐related and non–smoking‐related lung cancer in the Chinese population

Yi-long Wu, W. Zhong, F. Niu, 2015, Cancer.

Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines

Yi-long Wu, S. An, Xuchao Zhang, 2016, PloS one.

Prevalence of driver mutations in non-small-cell lung cancers in the People’s Republic of China

Yi-long Wu, L. Gou, 2014, Lung Cancer.

The coexistence of MET over-expression and an EGFR T790M mutation is related to acquired resistance to EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2016, Oncotarget.

Integrative Analyses of Lung Squamous Cell Carcinoma in Ten Chinese Patients with Transcriptome Sequencing.

Yi-long Wu, Jin-Ji Yang, Y. Lei, 2015, Journal of genetics and genomics = Yi chuan xue bao.

Stromal PD‐L1–Positive Regulatory T cells and PD‐1–Positive CD8‐Positive T cells Define the Response of Different Subsets of Non–Small Cell Lung Cancer to PD‐1/PD‐L1 Blockade Immunotherapy

Yi-long Wu, Jin-Ji Yang, W. Zhong, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer

Weitao Shen, D. Xiao, Jian Zhang, 2020, Aging.

Targeting c-Met overexpression for overcoming acquired resistance to EGFR TKIs in NSCLC.

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2015 .

GBP1 promotes erlotinib resistance via PGK1‑activated EMT signaling in non‑small cell lung cancer.

Jian Zhang, Ting Wei, Lifang Cheng, 2020, International journal of oncology.